Cellular therapy for prostate cancer patients also known as immunotherapy*, is a natural autologous cellular treatment that employs the use of dendritic cells, natural killer cells (NK cells), and lymphokine-activated killer cells (LAK cells) to suppress and eliminate malignant prostate cancer cells.
Immunotherapy for prostate cancer patients is a medically approved natural cancer treatment that has become one of the preferred cancer management therapies used by today’s top oncologist based on its high efficacy and synergistic capability. This is one of our most popular prostate cancer therapies in large part due to the low risk and affordable cost, a great choice for patients that are looking for alternatives to chemotherapy.
Cellular therapy for prostate cancer patients has also show great success in treatingdifferent types of cancer including breast cancer, ovarian cancer, lung cancer, and colon cancer patients.
*Other common names used for cellular therapy are immunotherapy, autologous cellular therapy, anti-cancer vaccines, autologous dendritic cell immunotherapy, differentiated stem cell therapy